Autologous Mesenchymal Stem Cell Therapy in Progressive Multiple Sclerosis: An Open Label Study

Publisher： Bentham Science Publishers

E-ISSN：  2212-3946|7|6|407-414

ISSN： 1574-888x

Source： Current Stem Cell Research & Therapy, Vol.7, Iss.6, 2012-12, pp. : 407-414

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Autologous Hematopoietic Stem Cell Transplantation for Systemic Sclerosis

By  

Current Stem Cell Research & Therapy, Vol. 6, Iss. 1, 2011-03 ,pp. : 16-28

Bentham Science Publishers

Access to resources Recommend Favorite

Mesenchymal and nonhematopoietic stem-cell therapy

By Horwitz EM  

Cytotherapy, Vol. 4, Iss. 6, 2002-10 ,pp. : 501-501

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Clinical and quality of life responses to high-dose chemotherapy plus autologous stem cell transplantation in patients with multiple sclerosis: two case reports

By Novik AA   Ionova TI   Bisaga GN   Kishtovich AV   Fedorenko DA   Ivanov RA   Gorodokin GI  

Cytotherapy, Vol. 7, Iss. 4, 2005-09 ,pp. : 363-367

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Mesenchymal Stem Cells for Multiple Sclerosis: Does Neural Differentiation Really Matter?

By  

Current Stem Cell Research & Therapy, Vol. 6, Iss. 1, 2011-03 ,pp. : 69-72

Bentham Science Publishers

Access to resources Recommend Favorite

Mesenchymal stem-cell therapy in a regulated environment

By Gee A  

Cytotherapy, Vol. 3, Iss. 5, 2001-09 ,pp. : 397-398

Ashgate Publishing Ltd

Access to resources Recommend Favorite